Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Teresa Latham"'
Autor:
Teresa Latham, Deanne Soares, Jennifer Knight-Madden, Robert J. Adams, Asha Badaloo, Carolyn Taylor-Bryan, Russell E. Ware, Margaret Wisdom-Phipps, William H. Schultz, Angela Rankine-Mullings, Adam Lane, Marvin Reid, Karen Aldred
Publikováno v:
British Journal of Haematology. 195:612-620
EXpanding Treatment for Existing Neurological Disease (EXTEND) investigated whether hydroxycarbamide lowers transcranial Doppler (TCD) velocities in Jamaican children with sickle cell anaemia (SCA) and elevated TCD velocity with or without previous s
Autor:
Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro, Mwesige Charles, Adam Lane, Susan E. Stuber, Abel Nkono Makubi, Russell E. Ware, Luke R. Smart
Publikováno v:
Blood. 140:447-448
Autor:
Alexandra Power-Hays, Min Dong, Kathryn McElhinney, Andrea L. Conroy, Teresa Latham, Adam Lane, Robert O. Opoka, Alexander A. Vinks, Russell E. Ware
Publikováno v:
Blood. 140:5461-5462
Autor:
Rosa M. Nieves, Teresa Latham, Nicolle Marte, Luisanna Sanchez, Melissa E. Berges, Gabriela S. Urcuyo, Carla Florencio, Carla Gonzalez, Paola Del Villar, Sheena Chen, Paula Reyes, Daniel Ramirez, Euladys Matos, Manuel Marinez, Susan E. Stuber, William Schultz, Adam Lane, Rafael Mena, Russell E. Ware
Publikováno v:
Blood. 140:451-452
Autor:
Adam Lane, Teresa Latham, Chandy C. John, Robert O. Opoka, Christopher M. Ndugwa, Heather Hume, Catherine Nabaggala, Phillip Kasirye, Russell E. Ware
Publikováno v:
New England Journal of Medicine. 382:2524-2533
Hydroxyurea has proven safety, feasibility, and efficacy in children with sickle cell anemia in sub-Saharan Africa, with studies showing a reduced incidence of vaso-occlusive events and reduced mortality. Dosing standards remain undetermined, however
Hydroxyurea reduces the transfusion burden in children with sickle cell anemia: the reach experience
Autor:
Alexandra Power-Hays, George A. Tomlinson, Leon Tshilolo, Brigida Santos, Thomas N. Williams, Peter Olupot-Olupot, Patrick T. McGann, Banu Aygun, Adam Lane, Susan E. Stuber, Teresa Latham, Russell E. Ware
Publikováno v:
American Society of Hematology Annual Scientifc conference
Introduction: Many children with sickle cell anemia (SCA) require blood transfusions, which carry risks and utilize a scarce resource globally, particularly in Africa. Realizing Effectiveness Across Continents with Hydroxyurea (REACH, NCT01966731) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffae011d2bd52494469c08ea124c95ce
http://hdl.handle.net/10044/1/99893
http://hdl.handle.net/10044/1/99893
Autor:
Russell E. Ware, Maria Nakafeero, Phillip Kasirye, Robert O. Opoka, Olatundun Williams, Teresa Latham, Chandy C. John, Christopher M. Ndugwa, Heather A. Hume, Adam Lane, Jennifer Tymon
Publikováno v:
Haematologica
Autor:
Luke R. Smart, Arielle G Hernandez, Erasmus Kamugisha, Emmanuela E. Ambrose, Adolfine Hokororo, Mwesige Charles, Erius Tebuka, Teresa Latham, Russell E. Ware, Medard Beyanga, Thad A Howard, Kathryn E McElhinney
Publikováno v:
Bulletin of the World Health Organization
To determine the regional- and district-level newborn prevalence of sickle cell trait and disease, and the prevalence of haemoglobin variants and genetic modifiers of sickle cell disease, in the nine regions of north-western United Republic of Tanzan
Autor:
Amanda Pfeiffer, Charles T. Quinn, Teresa Latham, Russell E. Ware, Min Dong, Alina Sadaf, Alexander A. Vinks
Publikováno v:
Blood. 138:980-980
Introduction: L-glutamine (Endari ®, Emmaus Medical, Inc.) is an amino acid approved for the treatment of sickle cell disease (SCD) by the United States Food and Drug Association (FDA) after 2 clinical trials demonstrated a reduction in painful epis
Autor:
Maria Nakafeero, Russell E. Ware, Susan E. Stuber, Peter Olupot-Olupot, Patrick T. McGann, George Tomlinson, Léon Tshilolo, Janet Adams, Adam Lane, Brigida Santos, Banu Aygun, Thomas N. Williams, Teresa Latham
Publikováno v:
Blood. 136:17-18
Introduction: Transcranial Doppler (TCD) screening data from Uganda, Tanzania, and Nigeria have documented elevated velocities in >20% of children with sickle cell anemia (SCA) not receiving hydroxyurea treatment. Realizing Effectiveness Across Conti